Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concurrent OPTIcal Coherence Tomography and frActional Flow REserve-guided Therapeutic Intervention in Patients With Coronary Artery Disease (OPTICARE-CAD)

NCT06182683 is registered in ClinicalTrials.gov with Korea University Guro Hospital as lead sponsor.

NCT NCT06182683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06182683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concurrent OPTIcal Coherence Tomography and frActional Flow REserve-guided Therapeutic Intervention in Patients With Coronary Artery Disease (OPTICARE-CAD)
Lead sponsor
Korea University Guro Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 30, 2023
Completion date
December 31, 2029
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atheroscleroses, coronary, coronary artery disease, image